Dermatitis herpetiformis

Source: Wikipedia, the free encyclopedia.
Dermatitis herpetiformis
Other namesDuhring's disease[1][2]
Characteristic rash of dermatitis herpetiformis
SpecialtyDermatology

Dermatitis herpetiformis (DH) is a

herpes virus; the name means that it is a skin inflammation having an appearance (Latin: -formis) similar to herpes
.

The age of onset is usually about 15 to 40, but DH also may affect children and the elderly. Men are slightly more affected than women.

gluten sensitivity.[7][8][9][10][11]

Dermatitis herpetiformis was first described by Louis Adolphus Duhring in 1884.[12] A connection between DH and coeliac disease was recognized in 1967.[12][13]

Signs and symptoms

Its characteristic rash resembles herpes and is the basis of its clinical name.

Dermatitis herpetiformis is characterized by intensely

papulovesicular eruptions, usually distributed symmetrically on extensor surfaces (buttocks, back of neck, scalp, elbows, knees, back, hairline, groin, or face).[1]: 616 [8][14] The blisters vary in size from very small up to 1 cm across. The condition is extremely itchy, and the desire to scratch may be overwhelming.[15] This sometimes causes the affected person to scratch the blisters off before they are examined by a physician.[8] Intense itching or burning sensations are sometimes felt before the blisters appear in a particular area.[4][16]

The signs and symptoms of DH typically appear around 30 to 40 years of age, although all ages may be affected.

blisters
. The rash rarely occurs on other mucous membranes, except the mouth or lips. The symptoms range in severity from mild to serious, but they are likely to disappear if gluten ingestion is avoided and appropriate treatment is administered.

Dermatitis herpetiformis symptoms are

fatigue. However, individuals with DH often have no gastrointestinal symptoms even if they have associated intestinal damage.[17]

The rash caused by dermatitis herpetiformis forms and disappears in three stages. In the first stage, the patient may notice a slight discoloration of the

crusts
.

Pathophysiology

Cross-reactivity hypothesis for the onset of dermatitis herpetiformis in people with celiac disease

In terms of pathology, the first signs of the condition may be observed within the

bullae
found in the skin affected by dermatitis herpetiformis are subepidermal and have rounded lateral borders.

When looked at under the

neutrophils. They have an increased prevalence in the areas where the dermis is closest to the epidermis
.

Direct IMF studies of uninvolved skin show IgA in the dermal papillae and patchy granular IgA along the basement membrane. The jejunal mucosa may show partial villous atrophy, but the changes tend to be milder than in coeliac disease.[18]

Immunological studies revealed findings that are similar to those of coeliac disease in terms of

autoantigens. The main autoantigen of dermatitis herpetiformis is epidermal transglutaminase (eTG), a cytosolic enzyme involved in cell envelope formation during keratinocyte differentiation.[7]

Various research studies have pointed out different potential factors that may play a larger or smaller role in the development of dermatitis herpetiformis. The fact that eTG has been found in precipitates of skin-bound IgA from skin affected by this condition has been used to conclude that dermatitis herpetiformis may be caused by a deposition of both IgA and eTG within the dermis. It is estimated that these deposits may resorb after ten years of following a gluten-free diet. Moreover, it is suggested that this condition is closely linked to

antibodies to gluten. These antibodies cross-react with eTG, and IgA/eTG complexes deposit within the papillary dermis to cause the lesions of dermatitis herpetiformis. These IgA deposits may disappear after long-term (up to ten years) avoidance of dietary gluten.[7]

CXCL8) in the lamina propria, recruiting neutrophils. Neutrophil recruitment results in a very rapid onset of inflammation. Therefore, co-infection with microbes that carry PAMPs may be necessary for the initial onset of symptoms in gluten sensitivity, but would not be necessary for successive encounters with gluten due to the production of memory B and memory T
cells (discussed below).

Dermatitis herpetiformis may be characterised based on inflammation in the skin and gut. Inflammation in the gut is similar to, and linked to,

plasma cells that secrete autoantibodies against tTG, which may be cross-reactive with epidermal transglutanimase (eTG). Class A antibodies (IgA) deposit in the gut. Some may bind to the CD89 (FcαRI) receptor on macrophages (M1) via their Fc region
(constant region). This will trigger endocytosis of the tTG-IgA complex, resulting in the activation of macrophages. Macrophages secrete more IL-8, propagating the neutrophil-mediated inflammatory response.

The purportedly cross-reactive autoantibodies may migrate to the skin in dermatitis herpetiformis. IgA deposits may form if the antibodies cross-react with epidermal transglutanimase (eTG). Some patients have eTG-specific antibodies instead of tTG-specific cross-reactive antibodies and the relationship between dermatitis herpetiformis and celiac disease in these patients is not fully understood. Macrophages may be stimulated to secrete IL-8 by the same process as is seen in the gut, causing neutrophils to accumulate at sites of high eTG concentrations in the

dermal papillae of the skin. Neutrophils produce pus in the dermal papillae, generating characteristic blisters. IL-31 accumulation at the blisters may intensify itching sensations. Memory B and T cells may become activated in the absence of PAMPs and DAMPs during successive encounters with tTG-modified gliadin complexes or modified gliadin alone, respectively. Symptoms of dermatitis herpetiformis are often resolved if patients avoid a gluten-rich diet.[19][20][21]

Diagnosis

See also: List of human leukocyte antigen alleles associated with cutaneous conditions

Dermatitis herpetiformis often is misdiagnosed, being confused with drug eruptions, contact dermatitis, dishydrotic eczema (dyshidrosis), and even scabies.[22] Other diagnoses in the differential diagnosis include bug bites and other blistering conditions such as bullous pemphigoid, linear IgA bullous dermatosis, and bullous systemic lupus erythematosus.

Micrograph of dermatitis herpetiformis: Subepidermal vesicles, with papillary neutrophil microabcesses, with neutrophil, eosinophil and lymphocytes infi ltrates in the superfi cial dermis. However, the histopathology is unspecific in approximately 35–40% of the cases,[23] and direct immunofluorescence is needed, showing deposition of IgA in the papillary dermis in a granular or fibrillar pattern.[24]

The diagnosis may be confirmed by a simple

false negatives
.

As with ordinary celiac disease, IgA against transglutaminase disappears (often within months) when patients eliminate gluten from their diet. Thus, for both groups of patients, it may be necessary to restart gluten for several weeks before testing may be done reliably. In 2010, Cutis reported an eruption labelled gluten-sensitive dermatitis which is clinically indistinguishable from dermatitis herpetiformis, but lacks the IgA connection,[27] similar to gastrointestinal symptoms mimicking coeliac disease but without the diagnostic immunological markers.[28]

Treatment

First-line therapy

A strict gluten-free diet must be followed,[25] and usually, this treatment will be a lifelong requirement. Avoidance of gluten will reduce any associated intestinal damage[15][25] and the risk of other complications. It can be very difficult to maintain a strict gluten-free diet, however, as contamination with gluten is common in many supposedly gluten-free foods and restaurants.

antibacterial, and its role in the treatment of DH, which is not caused by bacteria, is poorly understood. It may cause adverse effects, especially hemolytic anemia, so regular blood monitoring is required.[4]

Alternative treatment options

For individuals with DH unable to tolerate dapsone for any reason, alternative treatment options may include the following:

Combination therapy with nicotinamide and tetracyclines has been shown to be effective and well tolerated in some individuals who cannot tolerate dapsone or live in places where dapsone is not readily available.[31][32][33] While the mechanism of action of tetracyclines and nicotinamide in DH is unknown, it is speculated to be due to their immune-modulating effects.[32]

Topical steroid medications are also sometimes used in combination with dapsone and a gluten-free diet to alleviate the itchiness associated with the rash.[26]

Prognosis

Dermatitis herpetiformis generally responds well to

Sjögren's syndrome, sarcoidosis, vitiligo, and alopecia areata.[34] There has been an association of non-Hodgkin lymphoma in individuals who have dermatitis herpetiformis, although this risk decreases to less than the population risk with a strict gluten-free diet.[10][15][35]

Dermatitis herpetiformis does not usually cause complications on its own, without being associated with another condition. Complications from this condition, however, arise from the autoimmune character of the disease, as an overreacting immune system is a sign that something does not work well and might cause problems to other parts of the body that do not necessarily involve the

digestive system.[36]

Gluten intolerance and the body's reaction to it make the disease more worrying in what concerns the possible complications. This means that complications that may arise from dermatitis herpetiformis are the same as those resulting from coeliac disease, which include osteoporosis, certain kinds of gut cancer, and an increased risk of other autoimmune diseases such as thyroid disease.

The risks of developing complications from dermatitis herpetiformis decrease significantly if the affected individuals follow a gluten-free diet.

Epidemiology

Global estimates of the prevalence of dermatitis herpetiformis range from 1 in 400 to 1 in 10,000 people. Individuals of Northern European descent are most likely to be affected and estimates of the rates of DH in British and Finnish populations range from 30 in 100,000 to 75 in 100,000 people, respectively. The annual incidence rate of DH in these populations range from 0.8 to 2.7 per 100,000.[37]

People of all ages may be affected, although the mean age at diagnosis varies between 30 and 40 years of age.[6] There is a slight male predominance in DH for unknown reasons and it is associated with celiac disease and the haplotypes HLA-DQ2 and, less commonly, HLA-DQ8.[11]

Notable cases

It has been suggested that French revolutionary Jean-Paul Marat had DH. Marat was known to have a painful skin disease, from which he could only achieve relief by immersing himself in a bathtub filled with an herbal mixture; it was in this tub that he was famously assassinated, as portrayed in The Death of Marat. A researcher suggested in 1979 that the mysterious skin disease was DH based on these symptoms and this regimen of self-treatment.[37]

See also

References

  1. ^
    ISBN 0-07-138076-0
    .
  2. ISBN 978-1-4160-2999-1
    .
  3. PMID 17656946
    .
  4. ^ a b c d e "Dermatitis Herpetiformis". American Osteopathic College of Dermatology.
  5. ^ "Dermatitis Herpetiformis". Retrieved 2015-04-20.[permanent dead link]
  6. ^
    S2CID 23165241
    .
  7. ^ a b c Miller JL, Collins K, Sams HH, Boyd A (2007-05-18). "Dermatitis Herpetiformis". emedicine from WebMD. {{cite journal}}: Cite journal requires |journal= (help)
  8. ^
    PMID 18319038
    .
  9. ^ "Dermatitis Herpetiformis". Patient UK. Archived from the original on 2013-07-06. Retrieved 2009-07-22.
  10. ^ a b c "Dermatitis Herpetiformis". National Digestive Diseases Information Clearinghouse. Archived from the original on 2009-07-20. Retrieved 2009-07-22.
  11. ^
    PMID 9027962
    .
  12. ^ a b "What Is Dermatitis Herpetiformis?".
  13. PMID 17762854
    .
  14. PMID 15748547
    .
  15. ^ a b c d e "Dermatitis Herpetiformis". The HealthScout Network. Archived from the original on 2009-02-25. Retrieved 2009-07-22.
  16. ^
    PMID 9518950. Archived from the original
    on 2011-10-20. Retrieved 2009-07-22.
  17. ^ "Dermatitis Herpetiformis". Celiac Disease Foundation. Retrieved 2019-03-11.
  18. ^ "Perioral Dermatitis". Archived from the original on 2010-07-03. Retrieved 2010-06-23.
  19. ISBN 978-0815342434
    .
  20. PMID 25387490
    .
  21. PMID 21571167
    .
  22. ^ "What's The Diagnosis #9". Emergency Physicians Monthly. 15 April 2010. Retrieved 27 September 2011.
  23. PMID 25999753
    .
  24. PMID 29630215.{{cite journal}}: CS1 maint: multiple names: authors list (link
    ) Last Update: July 11, 2019.
  25. ^ a b c d "Dermatitis herpetiformis". DermNet NZ.
  26. ^ a b "Dermatitis herpetiformis". www.uptodate.com. Retrieved 11 March 2019.
  27. PMID 21284279
    .
  28. S2CID 7329242.{{cite journal}}: CS1 maint: multiple names: authors list (link
    )
  29. PMID 12165212
    .
  30. PMID 25922672
    .
  31. PMID 30390734
    .
  32. ^
    PMID 8445075
    .
  33. PMID 15412276
    .
  34. PMID 9115907
    .
  35. PMID 8949426
    .
  36. ^ "Herpetiformis Dermatitis Effects And Complications". Archived from the original on 2010-06-26. Retrieved 2010-06-23.
  37. ^
    PMID 396805
    .

Further reading

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Dermatitis_herpetiformis&oldid=1199903183"